These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5120538)

  • 1. Adverse drug reactions: the need for detection and control.
    Cluff LE
    Am J Epidemiol; 1971 Nov; 94(5):405-8. PubMed ID: 5120538
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse drug reactions: definition of the problem.
    Dunlop D
    Am J Epidemiol; 1971 Nov; 94(5):403-4. PubMed ID: 5120537
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance.
    Feinstein AR
    Clin Pharmacol Ther; 1974 Jul; 16(1):110-23. PubMed ID: 4843239
    [No Abstract]   [Full Text] [Related]  

  • 4. Methods of monitoring adverse reactions to drugs.
    Venulet J
    Prog Drug Res; 1977; 21():231-92. PubMed ID: 339270
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of drug-induced disease.
    Lawson DH
    Br J Clin Pharmacol; 1979 Jan; 7(1):13-8. PubMed ID: 367408
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring of adverse reactions to drugs in the United Kingdom.
    Inman WH
    Proc R Soc Med; 1970 Dec; 63(12):1302-4. PubMed ID: 5490790
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring adverse reactions to drugs: toward a therapeutic audit.
    Wade OL; Beeley L
    Int J Health Serv; 1974; 4(1):109-23. PubMed ID: 4597989
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of spontaneous reports of adverse reactions to drugs.
    Inman WH; Evans DA
    Br Med J; 1972 Sep; 3(5829):746-9. PubMed ID: 5077919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assuring the safety and efficacy of therapies.
    Stolley PD
    Int J Health Serv; 1974; 4(1):131-45. PubMed ID: 4597990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitored drug usage in a hospital environment.
    Macgregor AG
    N Z Med J; 1969 Jun; 69(445):356-9. PubMed ID: 5257555
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse drug reactions. A problem for drug regulatory agencies.
    Westerholm B
    Int J Clin Pharmacol; 1973 Apr; 7(2):183-9. PubMed ID: 4731286
    [No Abstract]   [Full Text] [Related]  

  • 12. Methods of studying prevalence and incidence of drug abuse.
    Bejerot N; Maurice-Bejerot C
    Scand J Soc Med; 1974; 2(2):99-104. PubMed ID: 4445833
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of adverse reactions within a drug surveillance program.
    Borda IT; Slone D; Jick H
    JAMA; 1968 Aug; 205(9):645-7. PubMed ID: 5695107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Questions on the monitoring of drug consumption at the 7th International pharmaceutical Congress held in Paris, July 16-21, 1978].
    Stika L
    Cesk Zdrav; 1979 Jul; 27(7):320-4. PubMed ID: 36993
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for adverse drug reactions.
    Bulpitt CJ
    Br J Hosp Med; 1977 Oct; 18(4):329, 333-4. PubMed ID: 912156
    [No Abstract]   [Full Text] [Related]  

  • 16. Post-marketing surveillance of adverse reactions to new medicines.
    Wilson AB
    Br Med J; 1977 Oct; 2(6093):1001-3. PubMed ID: 922357
    [No Abstract]   [Full Text] [Related]  

  • 17. Discrepancies in the reported frequency of cocaine-related deaths, United States, 1983 through 1988.
    Pollock DA; Holmgreen P; Lui KJ; Kirk ML
    JAMA; 1991 Oct 23-30; 266(16):2233-7. PubMed ID: 1920721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmarketing drug surveillance.
    Borden EK; Gardner JS; Westland MM; Gardner SD
    JAMA; 1984 Feb; 251(6):729-30. PubMed ID: 6694274
    [No Abstract]   [Full Text] [Related]  

  • 19. The rationale for a post-marketing surveillance.
    Westerholm B
    Hum Reprod; 1987 Jan; 2(1):41-4. PubMed ID: 3571446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-marketing surveillance: drug epidemiology.
    Borden EK
    J Int Med Res; 1981; 9(6):401-7. PubMed ID: 7319130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.